Stem cells are effective in disease management, personalized medicine and genomic testing. The increase in the public-private partnership investment in research for developing stem cell-based technology; encouraging regulatory framework, increasing investments in stem cell-based research, and growing alertness regarding the therapeutic potency of stem cell products; are the fuels for the escalation of the market.
Expert techniques are used for stem cell isolation, purification, and storage. High operational cost coupled with stem cell manufacturing. Therefore, stem cell products are frequently available at a higher price than pharmaceutical drugs and biologics. Technical limitations coupled with manufacturing scale-up, Socio-ethical concerns associated to the use of allogeneic and human embryonic stem cells; are the challenges to the market.
Government initiatives to boost the biotechnology and biopharmaceutical industries, increased market focus on mesenchymal stem cells and induced pluripotent stem cells. Regulatory reforms in the stem cell industries by the emerging countries meant for commercialization and research allied to stem cell therapy. Encouraging regulatory frameworks across developing countries are anticipated to offer huge opportunities to players in the market.
Due to the public-private funding and grants, extensive in progress stem cell research activities and support for the clinical evaluation of stem cells; North America owns the major share of the stem cell manufacturing market.
The global Stem Cell Manufacturing Market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as; Anterogen, Becton, Bio-Rad Laboratories, Bio-Techne Corporation, Cellgenix GMBH, Corning Inc., Danaher Corporation, Dickinson and Company, Eppendorf AG, Fujifilm Holdings Corporation, Getinge, Himedia Laboratories, Lonza Group AG, Merck Millipore, Miltenyi Biotec, Promocell, Sartorius AG, Stemcell Technologies, Takara Bio Group, Terumo BCT Inc., Thermo Fisher Scientific.
SPER Market Research study aims to provide market dynamics, demand and supply with yearly forecast to 2030. This report provides data for growth estimates and forecasts for Product segment- Consumables (Culture Media, Other Consumables), Instruments (Bioreactors and Incubators, Cell Sorters, Other Instruments), Stem Cell Lines [Embryonic stem cells (ESC), Hematopoietic stem cells (HSC), Induced Pluripotent Stem cells (iPSC), Mesenchymal stem cells (MSC), Multipotent adult progenitor stem cells, Neural Stem cells (NSC)]; for Application segment- Research Applications (Life science research, Drug discovery and development), Clinical Application (Allogenic stem cell therapy, Autologous stem cell therapy), Cell & Tissue Banking Applications; for End-User segment-Pharmaceutical & Biotechnology Companies, Academic institutes, Research laboratories & contract research organizations, Hospitals & surgical centers, Cell & tissue banks, Other End Users.
This report also provides the data for key regional segments of North America, Europe, Asia-Pacific and Rest of the World.
This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.